Although there is no randomized evidence that supports the use of SIB in ASCC, the RTOG 0529 trial – a single armed phase 2 study that used a dose painting technique - showed a trend towards a more favorable toxicity profile [ 23 ].
← all excerpts
Management of anal cancer patients - a pattern of care analysis in German-speaking countries.
1
—
—